<ѻý>Early Menopause Tied to Higher Risk of Respiratory Mortalityѻý> Greatest risk observed for women with bilateral oophorectomy Jun 13, 2024
<ѻý>Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?ѻý> News, features, and commentary about cancer-related issues Jun 13, 2024
<ѻý>AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancerѻý> AI detected 6.8% more clinically significant cancers, 20% fewer indolent cancers Jun 13, 2024
<ѻý>Tanning Salons Are Overdue for a Regulatory Burnѻý> In the meantime, don't forget to educate patients on the risks Jun 13, 2024
<ѻý>New Clues to Origin of T-Cell Lymphoma After CAR-T Therapyѻý> Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
<ѻý>Brigatinib Makes Its Case for ALK-Positive ALCL in Small Studyѻý> Second-gen ALK inhibitor induces high response rate, associated with impressive survival Jun 12, 2024
<ѻý>Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancerѻý> No difference in PFS, median OS favored control group Jun 12, 2024
<ѻý>Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancerѻý> Half of patients responded, but editorialists call for new directions in therapy development Jun 11, 2024
<ѻý>Middle-Age Man Presents With Necrotizing Mass on Noseѻý> Rare condition can be deadly without early diagnosis and treatment Jun 10, 2024
<ѻý>Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesotheliomaѻý> Immunotherapy may have been given too late, researchers suggested Jun 10, 2024
<ѻý>Lung Cancer Screening Rates Remain Low in the U.S., Especially in the Southѻý> But one study showed that patient navigation added to usual care may increase uptake Jun 10, 2024
<ѻý>Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patientsѻý> Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer Jun 08, 2024 podcast
<ѻý>Telomerase Inhibitor Approved for MDS-Related Anemiaѻý> Imetelstat indicated for lower-risk myelodysplastic syndromes with transfusion-dependent anemia Jun 07, 2024
<ѻý>Search for Missing Doctor; Energy Drinks and Sudden Death; Unusual Pandemic Cancersѻý> Health news and commentary gathered by ѻý staff Jun 07, 2024
<ѻý>Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapyѻý> All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years Jun 06, 2024
<ѻý>Increased Heart Risks With Newer Prostate Cancer Drugs, Meta-Analysis Showsѻý> Adding ARSIs to ADT for advanced disease doubled the risk of high-grade CV events, death Jun 06, 2024
<ѻý>'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trialѻý> News, features, and commentary about cancer-related issues Jun 06, 2024
<ѻý>Metformin Fails to Stop Early Prostate Cancer Progressionѻý> Study suggests it may even be detrimental in some groups of patients on active surveillance Jun 05, 2024
<ѻý>Docetaxel Tied to Less Taxane Neuropathy in Black Breast Cancer Patientsѻý> Dose-limiting toxicity has been linked with worse outcomes specifically in this population Jun 05, 2024
<ѻý>Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brainsѻý> Health news and commentary gathered by ѻý staff Jun 05, 2024
<ѻý>Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myelomaѻý> Two trials show positive outcomes Jun 04, 2024
<ѻý>Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanomaѻý> A third as many clinical events versus adjuvant therapy, 6 weeks of treatment for many patients Jun 04, 2024
<ѻý>ctDNA Analysis Not Enough to Guide Chemo De-Escalation in Early Pancreatic Cancerѻý> Adjuvant chemo de-escalation based on ctDNA had no effect on recurrence-free survival Jun 04, 2024
<ѻý>A Win for Liver Transplantation in Unresectable Metastatic Colorectal Cancerѻý> Three new trials address CRC liver metastases Jun 04, 2024
<ѻý>New Drug Effective for Tenosynovial Giant Cell Tumors, and With No Liver Concernsѻý> Current option for rare tumor requires a REMS to monitor for drug-induced liver injury Jun 04, 2024
Industry Clinic • Ad Insights <ѻý>What Will It Take to Deliver Both Health & Care in Oncology?ѻý> Jun 04, 2024
<ѻý>Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancersѻý> Clear cell histology "is what yields the super response we see in these trials," expert suggests Jun 04, 2024
<ѻý>IRS Sues Controversial Doctor; Congresswoman Has Cancer; Caffeine and Teensѻý> Health news and commentary gathered by ѻý staff Jun 04, 2024
<ѻý>Cheap Drug Eases Hot Flashes in Men With Prostate Cancerѻý> Anticholinergic oxybutynin for patients taking ADT also improved quality of life in the process Jun 03, 2024
<ѻý>Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumabѻý> Median OS was 55.9 months in the durvalumab group compared with 33.4 months in the placebo group Jun 03, 2024
<ѻý>Perioperative Chemo Extends Survival in Resectable Esophageal Cancerѻý> Improvement also observed in complete remission rates with FLOT over CROSS regimen Jun 03, 2024
<ѻý>Lymphadenectomy Not Needed in Advanced Ovarian Cancer With Optimal Surgeryѻý> PFS was not significantly different for those who skipped lymphadenectomy Jun 03, 2024
<ѻý>Triplet Notches Survival Win in Heavily Pretreated DLBCLѻý> Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant Jun 02, 2024
<ѻý>Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancerѻý> Trastuzumab deruxtecan extended its superiority versus chemotherapy into HER2-ultralow Jun 02, 2024
<ѻý>Novel CD40 Agonist-Chemo Combo Shows Promise in Pancreatic Cancerѻý> Frontline treatment with mitazalimab plus mFOLFIRINOX achieved responses in 40% of patients Jun 02, 2024
<ѻý>'Practice Changing' Trial for Inoperable Locally Advanced NSCLCѻý> EGFR testing now needed for all patients with stage III disease, experts say Jun 02, 2024
<ѻý>Intralesional Therapy for Melanoma Effective, May Have Systemic Activityѻý> Preoperative antibody fusion daromun significantly reduced relapse versus upfront surgery Jun 02, 2024
<ѻý>Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myelomaѻý> Second belantamab mafodotin-containing triplet to show potency in this setting Jun 02, 2024
<ѻý>Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancerѻý> No differences observed in quality of life metric, patient and caregiver satisfaction Jun 02, 2024
<ѻý>Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLCѻý> Unexpectedly offers a possible overall survival benefit, researchers say Jun 01, 2024